Stem cell

Weekly stem cell reads: parabiosis, UC Davis trial, HeLa lawsuit, gray hair

Parabiosis, anti-aging

Parabiosis refers to the joining together of two animals, typically rodents in research. They become one interconnected living system that shares blood. Research on mouse parabiosis has sparked much interest in anti-aging therapies. These might utilize “young” materials to help older people. Our first recommended read is a parabiosis paper. Before we jump into that, […]

Weekly stem cell reads: parabiosis, UC Davis trial, HeLa lawsuit, gray hair Read More »

Weekly stem cell reads: COVID kidney, FDA letter, H3.3, EO Wilson

EO Wilson

Happy New Year and get ready for another 364 more days of stem cell excitement and craziness in 2022. In the next day or two I’ll post my predictions for this new year. Recommended reads EO Wilson obit by Carl Zimmer in NYT. Who’s the next EO Wilson or someone like him with such big impact these

Weekly stem cell reads: COVID kidney, FDA letter, H3.3, EO Wilson Read More »

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court

regenerative medicine, stem cells 2021

The past year was all over the place for the stem cell and regenerative medicine field. As you can see in my scoring of my 21 predictions for 2021, quite a few things were surprises in terms of what did and didn’t happen. Here’s an overview of the top stories of the year in our

Top stem cell stories of 2021: COVID, diabetes, human embryos, clinics in court Read More »

Weekly stem cell reads: pending FDA verdict, blood vessels, RA

Cellular populations in the vascular wall, stem cell niche

Any day now we should get the verdict from the judge in the big stem cell clinic case here in California against Cell Surgical Network, et al. It seems that the FDA is waiting on this verdict before taking some major actions. If the judge rules against the agency it could throw the area into

Weekly stem cell reads: pending FDA verdict, blood vessels, RA Read More »